![]() |
Volumn 534, Issue 7607, 2016, Pages 314-316
|
Can you teach old drugs new tricks?
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
NEW DRUG;
CARBAZOLE DERIVATIVE;
DIPYRIDAMOLE;
EBSELEN;
GENERIC DRUG;
ORGANOSELENIUM DERIVATIVE;
PIRLINDOLE;
PYRROLE DERIVATIVE;
SILDENAFIL;
ZIDOVUDINE;
COST ANALYSIS;
DRUG DEVELOPMENT;
SAFETY;
ARTICLE;
CLINICAL RESEARCH;
CLINICAL TRIAL (TOPIC);
DRUG COST;
DRUG INDUSTRY;
DRUG MARKETING;
DRUG REPOSITIONING;
HUMAN;
NONHUMAN;
PATIENT SAFETY;
PHYSICIAN;
PRIORITY JOURNAL;
UNITED KINGDOM;
ANIMAL;
BIPOLAR DISORDER;
DRUG APPROVAL;
DRY EYE SYNDROMES;
ECONOMICS;
EPILEPSY;
MOUSE;
MULTIPLE SCLEROSIS;
NEOPLASMS;
OFF LABEL DRUG USE;
PATENT;
PHASE 2 CLINICAL TRIAL (TOPIC);
PRECLINICAL STUDY;
PROCEDURES;
STATISTICS AND NUMERICAL DATA;
ANIMALS;
AZOLES;
BIPOLAR DISORDER;
CARBAZOLES;
CLINICAL TRIALS, PHASE II AS TOPIC;
DIPYRIDAMOLE;
DRUG APPROVAL;
DRUG EVALUATION, PRECLINICAL;
DRUG INDUSTRY;
DRUG REPOSITIONING;
DRUGS, GENERIC;
DRY EYE SYNDROMES;
EPILEPSY;
HUMANS;
MICE;
MULTIPLE SCLEROSIS;
NEOPLASMS;
OFF-LABEL USE;
ORGANOSELENIUM COMPOUNDS;
PATENTS AS TOPIC;
SILDENAFIL CITRATE;
ZIDOVUDINE;
|
EID: 84975795401
PISSN: 00280836
EISSN: 14764687
Source Type: Journal
DOI: 10.1038/534314a Document Type: Article |
Times cited : (493)
|
References (5)
|